New hope for advanced lung cancer patients in clinical trial
NCT ID NCT07283198
Summary
This study is testing a new drug called JSKN033 for adults with advanced non-small cell lung cancer (NSCLC) that cannot be cured by surgery or radiation. The main goals are to see how safe the drug is and if it can shrink or control the cancer. The study will also measure how the drug moves through the body and how long its effects last.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER (NSCLC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.